Clinical Trial Update: Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) [Phase 2]

View source ↗

Summary

Phase 2 trial update for treatment of metastatic soft tissue sarcoma (leiomyosarcoma) under FIBROSARC USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Soft Tissue Sarcoma

Snippet

Sponsor: Philogen S.p.A. | Conditions: Leiomyosarcoma | Phase 2 | Status: UNKNOWN